Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H17NO4 |
| Molecular Weight | 299.3212 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(\C=C\C(=O)NCCC2=CC=C(O)C(O)=C2)C=C1
InChI
InChIKey=KZUJJPCTENPKOE-XBXARRHUSA-N
InChI=1S/C17H17NO4/c19-14-5-1-12(2-6-14)4-8-17(22)18-10-9-13-3-7-15(20)16(21)11-13/h1-8,11,19-21H,9-10H2,(H,18,22)/b8-4+
| Molecular Formula | C17H17NO4 |
| Molecular Weight | 299.3212 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:04:41 UTC 2023
by
admin
on
Sat Dec 16 09:04:41 UTC 2023
|
| Record UNII |
HBC0Y4WZ56
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
103188-46-1
Created by
admin on Sat Dec 16 09:04:41 UTC 2023 , Edited by admin on Sat Dec 16 09:04:41 UTC 2023
|
PRIMARY | |||
|
DTXSID50469749
Created by
admin on Sat Dec 16 09:04:41 UTC 2023 , Edited by admin on Sat Dec 16 09:04:41 UTC 2023
|
PRIMARY | |||
|
11630793
Created by
admin on Sat Dec 16 09:04:41 UTC 2023 , Edited by admin on Sat Dec 16 09:04:41 UTC 2023
|
PRIMARY | |||
|
HBC0Y4WZ56
Created by
admin on Sat Dec 16 09:04:41 UTC 2023 , Edited by admin on Sat Dec 16 09:04:41 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Among the compounds tested in this study, N-coumaroyldopamine and N-caffeoyldopamine were the two most potent compounds, able to increase cAMP at the concentrations < 0.05 uM in U937 cells. The decreasing order of potency was N-coumaroyldopamine > N- affeoyldopamine > N-feruloyldopamine > N-sinapoyldopamine > N-cinnamoyldopamine.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
230 uM IC50 vs in vitro prostaglandin synthesis
|
